Risk of dying of retinoblastoma in Mexican children.

Abstract

Medical and Pediatric OncologyVolume 38, Issue 3 p. 211-213 International Note Risk of dying of retinoblastoma in Mexican children Leal-Leal Carlos MD, Leal-Leal Carlos MD National Institute of Pediatrics (Instituto Nacional de Pediatría, Departamento de Oncología). Oncology Department, Mexico CitySearch for more papers by this authorRivera-Luna Roberto MD, Rivera-Luna Roberto MD National Institute of Pediatrics (Instituto Nacional de Pediatría, Departamento de Oncología). Oncology Department, Mexico CitySearch for more papers by this authorTovar-Guzmán Victor MD, MPH, MSc, Tovar-Guzmán Victor MD, MPH, MSc National Institute of Pediatrics (Instituto Nacional de Pediatría, Departamento de Oncología). Oncology Department, Mexico CitySearch for more papers by this authorHernández-Girón Carlos MD, MSc, Corresponding Author Hernández-Girón Carlos MD, MSc [email protected] National Institute of Public Health (Instituto Nacional de Salud Pública) Center for Research in Population Health (Centro de Investigación en Salud Poblacional) Cuernavaca, Morelos, MexicoNational Institute of Public Health, Av. Universidad 655, C.P. 62508, Cuernavaca, Morelos, México.Search for more papers by this authorLazcano-Ponce Eduardo MD, MSc, PhD, Lazcano-Ponce Eduardo MD, MSc, PhD National Institute of Public Health (Instituto Nacional de Salud Pública) Center for Research in Population Health (Centro de Investigación en Salud Poblacional) Cuernavaca, Morelos, MexicoSearch for more papers by this author Leal-Leal Carlos MD, Leal-Leal Carlos MD National Institute of Pediatrics (Instituto Nacional de Pediatría, Departamento de Oncología). Oncology Department, Mexico CitySearch for more papers by this authorRivera-Luna Roberto MD, Rivera-Luna Roberto MD National Institute of Pediatrics (Instituto Nacional de Pediatría, Departamento de Oncología). Oncology Department, Mexico CitySearch for more papers by this authorTovar-Guzmán Victor MD, MPH, MSc, Tovar-Guzmán Victor MD, MPH, MSc National Institute of Pediatrics (Instituto Nacional de Pediatría, Departamento de Oncología). Oncology Department, Mexico CitySearch for more papers by this authorHernández-Girón Carlos MD, MSc, Corresponding Author Hernández-Girón Carlos MD, MSc [email protected] National Institute of Public Health (Instituto Nacional de Salud Pública) Center for Research in Population Health (Centro de Investigación en Salud Poblacional) Cuernavaca, Morelos, MexicoNational Institute of Public Health, Av. Universidad 655, C.P. 62508, Cuernavaca, Morelos, México.Search for more papers by this authorLazcano-Ponce Eduardo MD, MSc, PhD, Lazcano-Ponce Eduardo MD, MSc, PhD National Institute of Public Health (Instituto Nacional de Salud Pública) Center for Research in Population Health (Centro de Investigación en Salud Poblacional) Cuernavaca, Morelos, MexicoSearch for more papers by this author First published: 05 February 2002 https://doi.org/10.1002/mpo.1314Citations: 9AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume38, Issue3March 2002Pages 211-213 RelatedInformation